Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$133.41
-3.71-2.71%
At close: -
$133.41
0.000.00%
After Hours: Mar 28, 4:00 PM EDT
Comments
Loading...
Repligen Analyst Ratings and Price Targets | NASDAQ:RGEN | Benzinga
Repligen Corp has a consensus price target of $186.57 based on the ratings of 17 analysts. The high is $220 issued by Keybanc on February 15, 2024. The low is $155 issued by Evercore ISI Group on March 18, 2025. The 3 most-recent analyst ratings were released by Evercore ISI Group, RBC Capital, and JP Morgan on March 18, 2025, February 21, 2025, and February 21, 2025, respectively. With an average price target of $186.67 between Evercore ISI Group, RBC Capital, and JP Morgan, there's an implied 39.92% upside for Repligen Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Evercore ISI Group
RBC Capital
JP Morgan
HC Wainwright & Co.
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for Repligen
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/18/2025 | Buy Now | 16.18% | Evercore ISI Group | Daniel Markowitz15% | → $155 | Initiates | → In-Line | Get Alert |
| 02/21/2025 | Buy Now | 53.66% | RBC Capital | Conor McNamara36% | $203 → $205 | Maintains | Outperform | Get Alert |
| 02/21/2025 | Buy Now | 49.91% | JP Morgan | Rachel Vatnsdal64% | $190 → $200 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | 34.92% | HC Wainwright & Co. | Raghuram Selvaraju42% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2025 | Buy Now | 27.43% | Canaccord Genuity | Kyle Mikson33% | $165 → $170 | Maintains | Hold | Get Alert |
| 01/23/2025 | Buy Now | 34.92% | HC Wainwright & Co. | Raghuram Selvaraju42% | $240 → $180 | Maintains | Buy | Get Alert |
| 12/17/2024 | Buy Now | 23.68% | Canaccord Genuity | Kyle Mikson33% | → $165 | Initiates | → Hold | Get Alert |
| 11/14/2024 | Buy Now | — | Wolfe Research | Doug Schenkel71% | — | Initiates | → Peer Perform | Get Alert |
| 09/26/2024 | Buy Now | 53.66% | RBC Capital | Conor McNamara36% | $205 → $205 | Reiterates | Outperform → Outperform | Get Alert |
| 08/27/2024 | Buy Now | 34.92% | Wells Fargo | Brandon Couillard70% | → $180 | Initiates | → Overweight | Get Alert |
| 08/05/2024 | Buy Now | — | Benchmark | Robert Wasserman49% | — | Reiterates | → Hold | Get Alert |
| 07/31/2024 | Buy Now | 49.91% | JP Morgan | Rachel Vatnsdal64% | $190 → $200 | Maintains | Overweight | Get Alert |
| 07/31/2024 | Buy Now | 38.67% | UBS | Elizabeth Garcia71% | $205 → $185 | Maintains | Buy | Get Alert |
| 07/31/2024 | Buy Now | 42.42% | RBC Capital | Conor McNamara36% | $190 → $190 | Reiterates | Outperform → Outperform | Get Alert |
| 07/30/2024 | Buy Now | 27.43% | Stephens & Co. | Jacob Johnson57% | $170 → $170 | Reiterates | Overweight → Overweight | Get Alert |
| 06/26/2024 | Buy Now | 16.18% | Deutsche Bank | Justin Bowers48% | $180 → $155 | Upgrade | Hold → Buy | Get Alert |
| 06/18/2024 | Buy Now | — | Guggenheim | Subbu Nambi43% | — | Initiates | → Neutral | Get Alert |
| 05/02/2024 | Buy Now | 49.91% | JP Morgan | Rachel Vatnsdal64% | $230 → $200 | Maintains | Overweight | Get Alert |
| 02/22/2024 | Buy Now | 55.16% | Stifel | Daniel Arias79% | $165 → $207 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 64.91% | Keybanc | Paul Knight55% | $210 → $220 | Maintains | Overweight | Get Alert |
| 12/20/2023 | Buy Now | 57.41% | JP Morgan | Rachel Vatnsdal64% | $170 → $210 | Maintains | Overweight | Get Alert |
| 12/04/2023 | Buy Now | — | Benchmark | Robert Wasserman49% | — | Downgrade | Buy → Hold | Get Alert |
| 11/02/2023 | Buy Now | 27.43% | UBS | Elizabeth Garcia71% | $210 → $170 | Maintains | Buy | Get Alert |
| 11/01/2023 | Buy Now | 23.68% | Stifel | Daniel Arias79% | $200 → $165 | Maintains | Buy | Get Alert |
| 11/01/2023 | Buy Now | 49.91% | RBC Capital | Conor McNamara36% | $207 → $200 | Maintains | Outperform | Get Alert |
| 11/01/2023 | Buy Now | 57.41% | Keybanc | Paul Knight55% | $240 → $210 | Maintains | Overweight | Get Alert |
| 10/17/2023 | Buy Now | 34.92% | JP Morgan | Rachel Vatnsdal64% | $200 → $180 | Maintains | Overweight | Get Alert |
| 09/08/2023 | Buy Now | 43.17% | RBC Capital | Conor McNamara36% | → $191 | Reiterates | Outperform → Outperform | Get Alert |
| 09/06/2023 | Buy Now | 43.17% | RBC Capital | Conor McNamara36% | → $191 | Reiterates | Outperform → Outperform | Get Alert |
| 08/03/2023 | Buy Now | 49.91% | Craig-Hallum | Matt Hewitt62% | $207 → $200 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | 46.17% | RBC Capital | Conor McNamara36% | $157 → $195 | Maintains | Outperform | Get Alert |
| 08/03/2023 | Buy Now | 49.91% | Stephens & Co. | Jacob Johnson57% | $180 → $200 | Maintains | Overweight | Get Alert |
| 07/20/2023 | Buy Now | 38.67% | Wells Fargo | Timothy Daley54% | → $185 | Initiates | → Overweight | Get Alert |
| 07/06/2023 | Buy Now | 16.93% | RBC Capital | Conor McNamara36% | → $156 | Upgrade | Sector Perform → Outperform | Get Alert |
| 05/03/2023 | Buy Now | 17.68% | RBC Capital | Conor McNamara36% | $170 → $157 | Maintains | Sector Perform | Get Alert |
| 05/03/2023 | Buy Now | 57.41% | Stifel | Daniel Arias79% | $225 → $210 | Maintains | Buy | Get Alert |
| 05/03/2023 | Buy Now | 49.91% | Stephens & Co. | Jacob Johnson57% | $220 → $200 | Maintains | Overweight | Get Alert |
| 03/28/2023 | Buy Now | 72.4% | Benchmark | Robert Wasserman49% | → $230 | Initiates | → Buy | Get Alert |
| 02/23/2023 | Buy Now | 79.9% | Keybanc | Paul Knight55% | $260 → $240 | Maintains | Overweight | Get Alert |
| 01/06/2023 | Buy Now | 49.91% | SVB Leerink | Puneet Souda57% | $230 → $200 | Maintains | Outperform | Get Alert |
| 12/14/2022 | Buy Now | 34.92% | Deutsche Bank | Justin Bowers48% | → $180 | Initiates | → Hold | Get Alert |
| 12/07/2022 | Buy Now | 42.42% | RBC Capital | Conor McNamara36% | → $190 | Initiates | → Sector Perform | Get Alert |
| 08/03/2022 | Buy Now | 106.13% | Stephens & Co. | Jacob Johnson57% | $220 → $275 | Maintains | Overweight | Get Alert |
| 08/03/2022 | Buy Now | 87.39% | SVB Leerink | Puneet Souda57% | $220 → $250 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | 94.89% | Keybanc | Paul Knight55% | $245 → $260 | Maintains | Overweight | Get Alert |
| 07/20/2022 | Buy Now | 59.66% | UBS | Elizabeth Garcia71% | → $213 | Initiates | → Buy | Get Alert |
| 04/28/2022 | Buy Now | 83.64% | Keybanc | Paul Knight55% | $335 → $245 | Maintains | Overweight | Get Alert |
| 04/28/2022 | Buy Now | 64.91% | SVB Leerink | Puneet Souda57% | $250 → $220 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Repligen (RGEN) stock?
The latest price target for Repligen (NASDAQ:RGEN) was reported by Evercore ISI Group on March 18, 2025. The analyst firm set a price target for $155.00 expecting RGEN to rise to within 12 months (a possible 16.18% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Repligen (RGEN)?
The latest analyst rating for Repligen (NASDAQ:RGEN) was provided by Evercore ISI Group, and Repligen initiated their in-line rating.
When was the last upgrade for Repligen (RGEN)?
The last upgrade for Repligen Corp happened on June 26, 2024 when Deutsche Bank raised their price target to $155. Deutsche Bank previously had a hold for Repligen Corp.
When was the last downgrade for Repligen (RGEN)?
The last downgrade for Repligen Corp happened on December 4, 2023 when Benchmark changed their price target from N/A to N/A for Repligen Corp.
When is the next analyst rating going to be posted or updated for Repligen (RGEN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Repligen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Repligen was filed on March 18, 2025 so you should expect the next rating to be made available sometime around March 18, 2026.
Is the Analyst Rating Repligen (RGEN) correct?
While ratings are subjective and will change, the latest Repligen (RGEN) rating was a initiated with a price target of $0.00 to $155.00. The current price Repligen (RGEN) is trading at is $133.41, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.